Sherpa, Cathay Lead Brain-Spine Interface Tech
28 May 2026
US$ 20.00
Sherpa Healthcare Partners, Cathay Capital and Shanghai SSCI Leading Private Equity Fund Management Co Ltd have ......
Related Publications
Subscribers’ Weekly ending 29 May 2026...
T Capital Partners has agreed to sell its entire 100% stake in MicroBiopharm Japan Co Ltd (MicroBiopharm) to India’s G...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.